✦ LIBER ✦

Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer: a retrospective review of 65 Japanese patients

✍ Scribed by Akihiro Tamiya; Kentaro Yamazaki; Narikazu Boku; Nozomu Machida; Takashi Kojima; Keisei Taku; Hirofumi Yasui; Akira Fukutomi; Shuichi Hironaka; Yusuke Onozawa

Publisher: Springer
Year: 2009
Tongue: English
Weight: 317 KB
Volume: 14
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-009-0911-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of irinotecan and infusional fluo

Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer

✍ Nozomu Fuse; Toshihiko Doi; Atsushi Ohtsu; Tomonori Yano; Yasuo Hamamoto; Keiko 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 252 KB

Increased toxicity and lack of efficacy

Increased toxicity and lack of efficacy of Rofecoxib in combination with chemotherapy for treatment of metastatic colorectal cancer: A phase II study

✍ Carlos R. Becerra; Eugene P. Frenkel; Raheela Ashfaq; Richard B. Gaynor 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 207 KB 👁 1 views

## Abstract Preclinical and clinical models have demonstrated that cyclooxygenase‐2 (COX‐2) is overexpressed in primary and metastatic colorectal tumors. In preclinical models, there appears to be additive or synergistic effects when combining 5‐Fluorouracil (5‐FU) with nonsteroidal anti‐inflammato

Combination chemotherapy of biweekly iri

Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients

✍ Koji Okabayashi; Hirotoshi Hasegawa; Yoshiyuki Ishii; Takashi Endo; Hiroki Ochia 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 392 KB